BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8958606)

  • 1. Intraoperative heparin anticoagulation and its reversal.
    Wakefield TW; Stanley JC
    Semin Vasc Surg; 1996 Dec; 9(4):296-302. PubMed ID: 8958606
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation and reversal paradigms: is too much of a good thing bad?
    Levy JH; Tanaka KA
    Anesth Analg; 2009 Mar; 108(3):692-4. PubMed ID: 19224768
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
    Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
    J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate.
    Muralidharan-Chari V; Kim J; Mousa SA
    Thromb Res; 2017 Jul; 155():128-130. PubMed ID: 28538195
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy during cardiopulmonary bypass.
    Yavari M; Becker RC
    J Thromb Thrombolysis; 2008 Dec; 26(3):218-28. PubMed ID: 18931979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation.
    Kaneda H; Suzuki J; Hosokawa G; Tanaka S; Hiroe Y; Saito S
    Int J Cardiol; 2005 Oct; 105(1):111-2. PubMed ID: 16207558
    [No Abstract]   [Full Text] [Related]  

  • 10. Does Routine Reversal of Heparin With Protamine Sulphate in Patients Undergoing Carotid Endarterectomy Reduce Bleeding Complications Without Leading to Increased Thromboembolic Complications?
    Lynch NP; Kavanagh EG
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):150. PubMed ID: 26482510
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk management in cardiac anesthesia: analysis of critical issues. Introduction.
    Ellison N; Pierce EC
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):1-2. PubMed ID: 9583567
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin and protamine requirements of patients in chronic renal failure.
    Akpek EA; Dönmez A; Erol E; Sekerci S; Arslan G
    Transplant Proc; 1998 May; 30(3):805-6. PubMed ID: 9595106
    [No Abstract]   [Full Text] [Related]  

  • 13. Can you reheparinize after heparinase-I?
    Roth JV
    Anesth Analg; 2002 Aug; 95(2):501; author reply 501-2. PubMed ID: 12145087
    [No Abstract]   [Full Text] [Related]  

  • 14. Low molecular weight heparin.
    Vanpee D; Gillet JB; Swine C
    Ann Emerg Med; 2000 Sep; 36(3):277-8. PubMed ID: 10969239
    [No Abstract]   [Full Text] [Related]  

  • 15. Must heparin be neutralized following open-heart operations?
    Castaneda AR
    J Thorac Cardiovasc Surg; 1966 Nov; 52(5):716-24. PubMed ID: 5955183
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonfatal self-poisoning with LMW heparin and the use of antidote.
    Bjornaas MA; Jacobsen EM; Jacobsen D
    Thromb Res; 2010 Nov; 126(5):e403-5. PubMed ID: 20870279
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of prekallikrein deficiency during cardiac surgery.
    Eeckhoudt SL; Momeni M; Matta A; Latinne D; Arnout J; Hermans C
    Thromb Haemost; 2010 Apr; 103(4):866-7. PubMed ID: 20135073
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin utilization during arterial revascularization.
    Collins GJ; Kimball DB; Rich NM; Andersen CA; McDonald PT
    Am Surg; 1978 Dec; 44(12):753-7. PubMed ID: 367236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tooth removal and anticoagulant therapy.
    Dios PD; Feijoo JF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):248-9. PubMed ID: 11552136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.